Evaluation of biophysical skin parameters and hair changes in patients with acne vulgaris treated with isotretinoin, and the effect of biotin use on these parameters
- PMID: 33682085
- DOI: 10.1111/ijd.15485
Evaluation of biophysical skin parameters and hair changes in patients with acne vulgaris treated with isotretinoin, and the effect of biotin use on these parameters
Abstract
Aim: Impairment of biotin metabolism with the use of isotretinoin and the mucocutaneous side effects observed in patients using isotretinoin suggests that they are a result of decreased enzyme activity. We aimed to determine the pattern of skin and hair changes in patients with acne receiving isotretinoin and how these changes were affected by biotin added to the treatment.
Materials and methods: Sixty patients were divided into two groups. Each group contained 30 patients. Groups A and B received 0.5 mg/kg/day isotretinoin, and 10 mg/day biotin supplement was added to Group B. Both groups were evaluated using a digital dermoscope for hair changes and with a DermaLab® Combo device for transepidermal water loss (TEWL), skin retraction, skin hydration, and skin sebum levels at the beginning and end of the fourth month.
Results: In group B, the anagen hair ratio increased (P = 0.034) and the telogen hair ratio decreased significantly (P = 0.003). Skin sebum and the skin retraction values decreased in both groups. Skin hydration decreased significantly in group A (P = 0.001), but there was no significant decrease in group B (P = 0.43).
Conclusion: Biotin (10 mg/day) given in addition to isotretinoin treatment decreased telogen and increased anagen hair rates and helped to maintain skin hydration. The use of 10 mg/day biotin can prevent the mucocutaneous adverse effects of isotretinoin treatment.
© 2021 the International Society of Dermatology.
Similar articles
-
Effect of Evening Primrose Oil Supplementation on Selected Parameters of Skin Condition in a Group of Patients Treated with Isotretinoin-A Randomized Double-Blind Trial.Nutrients. 2022 Jul 21;14(14):2980. doi: 10.3390/nu14142980. Nutrients. 2022. PMID: 35889936 Free PMC article. Clinical Trial.
-
Evaluation of biophysical skin parameters and assessment of hair growth in patients with acne treated with isotretinoin.Postepy Dermatol Alergol. 2013 Dec;30(6):343-9. doi: 10.5114/pdia.2013.39432. Epub 2013 Dec 18. Postepy Dermatol Alergol. 2013. PMID: 24493996 Free PMC article.
-
Effects of isotretinoin on the hair cycle.J Cosmet Dermatol. 2019 Apr;18(2):647-651. doi: 10.1111/jocd.12800. Epub 2018 Oct 23. J Cosmet Dermatol. 2019. PMID: 30350907 Clinical Trial.
-
Comparing the frequency of isotretinoin-induced hair loss at <0.5-mg/kg/d versus ≥0.5-mg/kg/d dosing in acne patients: A systematic review.JAAD Int. 2022 Feb 10;6:125-142. doi: 10.1016/j.jdin.2022.01.002. eCollection 2022 Mar. JAAD Int. 2022. PMID: 35199047 Free PMC article. Review.
-
Isotretinoin. A review of its pharmacological properties and therapeutic efficacy in acne and other skin disorders.Drugs. 1984 Jul;28(1):6-37. doi: 10.2165/00003495-198428010-00002. Drugs. 1984. PMID: 6235105 Review.
Cited by
-
Use of Oral Supplements and Topical Adjuvants for Isotretinoin-Associated Side Effects: A Narrative Review.Skin Appendage Disord. 2024 Feb;10(1):1-9. doi: 10.1159/000533963. Epub 2023 Oct 20. Skin Appendage Disord. 2024. PMID: 38313565 Free PMC article. Review.
-
Effect of Evening Primrose Oil Supplementation on Selected Parameters of Skin Condition in a Group of Patients Treated with Isotretinoin-A Randomized Double-Blind Trial.Nutrients. 2022 Jul 21;14(14):2980. doi: 10.3390/nu14142980. Nutrients. 2022. PMID: 35889936 Free PMC article. Clinical Trial.
-
Exploring Acne Treatments: From Pathophysiological Mechanisms to Emerging Therapies.Int J Mol Sci. 2024 May 13;25(10):5302. doi: 10.3390/ijms25105302. Int J Mol Sci. 2024. PMID: 38791344 Free PMC article. Review.
-
Biotin for Hair Loss: Teasing Out the Evidence.J Clin Aesthet Dermatol. 2024 Aug;17(8):56-61. J Clin Aesthet Dermatol. 2024. PMID: 39148962 Free PMC article. Review.
-
Reduction in Facial Sebum Production Following Treatment with Clascoterone Cream 1% in Patients with Acne Vulgaris: 12-Week Interim Analysis.Dermatol Ther (Heidelb). 2025 Sep;15(9):2657-2666. doi: 10.1007/s13555-025-01495-y. Epub 2025 Jul 19. Dermatol Ther (Heidelb). 2025. PMID: 40682762 Free PMC article.
References
-
- Önder S, Ozturk M. Can monocyte/HDL show inflammatory activity of isotretinoin treatment in acne patients? Cutan Ocul Toxicol 2020; 9: 1-4.
-
- Zouboulis CC, Bettoli V. Management of severe acne. Br J Dermatol 2015; 172: 27-36.
-
- Bergler-Czop B, Brzezińska-Wcisło L. The new therapy schema of the various kinds of acne based on the mucosa-skin side effects of the retinoids. Cutan Ocul Toxicol 2012; 31: 188-194.
-
- Zempleni J, Hassan YI, Wijeratne SS. Biotin and biotinidase deficiency. Expert Rev Endocrinol Metab 2008; 3(6): 715-724.
-
- Schulpis KH, Georgala S, Papakonstantinou ED, et al. The effect of isotretinoin on biotinidase activity. Skin Pharmacol Physiol 1999; 12: 28-33.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical